300401.SZ
Zhejiang Garden Biopharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 14.14
−8.42%Margins
Gross margin
53.7%
EBITDA margin
44.5%
EBIT margin
25.3%
Net margin
21.8%
FCF margin
16.6%
7.3%
Return on equity
4.3%
Return on assets
7.1%
Return on invested capital
0.20x
Asset turnover
CNY 530.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026